| Primary |
| Ill-defined Disorder |
34.6% |
| Hormone Replacement Therapy |
19.2% |
| Hypercholesterolaemia |
11.5% |
| Prophylaxis |
11.5% |
| Sleep Disorder |
11.5% |
| Hot Flush |
3.8% |
| Hysterosalpingo-oophorectomy |
3.8% |
| Osteoporosis |
3.8% |
|
| Perforated Ulcer |
37.5% |
| Malaise |
12.5% |
| Pharmaceutical Product Complaint |
12.5% |
| Product Substitution Issue |
12.5% |
| Visual Acuity Reduced |
12.5% |
| Vulvitis |
12.5% |
|
| Secondary |
| Hormone Replacement Therapy |
69.8% |
| Menopausal Symptoms |
12.5% |
| Menopause |
4.7% |
| Depression |
1.6% |
| Hypertension |
1.6% |
| Hysterectomy |
1.4% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
| Anxiety |
1.0% |
| Hypothyroidism |
0.7% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Hormone Therapy |
0.6% |
| Hot Flush |
0.6% |
| Menstrual Disorder |
0.6% |
| Migraine |
0.6% |
| Cerebrovascular Accident |
0.4% |
| Coagulopathy |
0.4% |
| Drug Use For Unknown Indication |
0.4% |
| Oestrogen Replacement Therapy |
0.4% |
| Prophylaxis |
0.4% |
| Blood Cholesterol |
0.3% |
|
| Breast Cancer Female |
35.5% |
| Breast Cancer |
33.5% |
| Breast Cancer Metastatic |
9.7% |
| Ovarian Cancer Metastatic |
3.2% |
| Drug Ineffective |
2.6% |
| Myocardial Infarction |
2.6% |
| Ovarian Cancer |
2.6% |
| Vitrectomy |
1.9% |
| Thrombosis |
1.3% |
| Alopecia |
0.6% |
| Breast Cancer Stage Ii |
0.6% |
| Cerebrovascular Accident |
0.6% |
| Contralateral Breast Cancer |
0.6% |
| Dehydration |
0.6% |
| Hepatic Neoplasm Malignant |
0.6% |
| Metrorrhagia |
0.6% |
| Non-hodgkin's Lymphoma |
0.6% |
| Pancreatitis |
0.6% |
| Product Quality Issue |
0.6% |
| Pulmonary Embolism |
0.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.3% |
| Pain |
7.5% |
| Hormone Replacement Therapy |
7.2% |
| Osteoporosis |
7.2% |
| Asthma |
6.6% |
| Product Used For Unknown Indication |
4.7% |
| Rheumatoid Arthritis |
3.4% |
| Depression |
3.1% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Lipids Increased |
3.1% |
| Insomnia |
2.8% |
| Anxiety |
2.5% |
| Multiple Sclerosis |
2.5% |
| Rhinitis Allergic |
2.5% |
| Smoking Cessation Therapy |
2.5% |
| Vitamin Supplementation |
2.5% |
| Blood Cholesterol Increased |
1.9% |
| Crohn's Disease |
1.9% |
| Hypersensitivity |
1.9% |
| Ill-defined Disorder |
1.9% |
|
| Neuropathy Peripheral |
9.7% |
| Suicidal Ideation |
9.7% |
| Tinnitus |
9.7% |
| Respiratory Failure |
6.5% |
| Vomiting |
6.5% |
| Dyspnoea |
4.8% |
| Pyrexia |
4.8% |
| Tremor |
4.8% |
| Weight Decreased |
4.8% |
| Weight Increased |
4.8% |
| Wound Dehiscence |
4.8% |
| Incorrect Dose Administered |
3.2% |
| Injection Site Pain |
3.2% |
| Insomnia |
3.2% |
| Muscular Weakness |
3.2% |
| Palpitations |
3.2% |
| Procedural Complication |
3.2% |
| Rash Pruritic |
3.2% |
| Sleep Disorder |
3.2% |
| Stent Placement |
3.2% |
|
